SCHEMBL4158385

SCHEMBL4158385

CN(C(=O)N(Cc1cccnc1)C(=O)c1c(F)cccc1F)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.43
ABCB1 P08183 2/20 0.38
ABCC1 P33527 2/20 0.38
ALDH1A1 P00352 2/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RIPK1 Q13546 1/20 0.36
MAPT P10636 1/20 0.35
GFER P55789 1/20 0.35
KMT2A Q03164 1/20 0.35
PKM P14618 1/20 0.35
GPBAR1 Q8TDU6 3/20 0.35
NR1H4 Q96RI1 1/20 0.35
PDK1 Q15118 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNA4 P43681 1/20 0.34
TP53 P04637 2/20 0.34
CLK1 P49759 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4159030 0.89 TDP1 (0.45) ALDH1A1RAB9AMAPTKMT2ALMNA
SCHEMBL4166881 0.84 MEN1 (0.41) ALDH1A1RAB9AKMT2ACLK1LMNA
SCHEMBL4159011 0.83 RAB9A (0.45) ALDH1A1RAB9AKMT2ALMNA
SCHEMBL4150006 0.83 MEN1 (0.43) ALDH1A1MAPTKMT2APDK1TP53
SCHEMBL4157996 0.82 RORC (0.35) MAPTLMNA
SCHEMBL4142662 0.81 RORC (0.34) MAPTGPBAR1LMNA
SCHEMBL13774522 0.81 MAPT (0.35) NPSR1MAPTLMNA
SCHEMBL4141989 0.80 KDM4E (0.43) ALDH1A1KMT2AGPBAR1
SCHEMBL4158131 0.80 RORC (0.33) ABCB1ABCC1MAPTGPBAR1LMNA
SCHEMBL4145562 0.80 RORC (0.33) MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 CYP3A4 1656/4885ABCB1 489/4885ABCC1 345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.